Follow The Filings

MCB Metropolitan Bank Holding Corporation

Financials, filed as METROPOLITAN BK HLDG CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.1%
  • $4.9M
  • 1 reduce

In 2026 Q2 George Soros trimmed Metropolitan Bank.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (George Soros, Soros Fund Management). Not free-float ownership.

  1. George Soros Reduce 0.06%

Who owns MCB

Sorted by value, long equity only, as of 2026 Q2.

History
George Soros, Soros Fund Management 0.06%, was 0.07% Reduce −33.3% 50,000 $4.9M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by MCB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MCB insider trades
  • $253K bought by 3 insiders
  • $4.1M sold by 3 insiders outside a trading plan
  • $389K sold by 1 insider under 10b5-1 plans
  1. Dale C Fredston Director
    Sale
    $178K 2,000 shares at $89.09 12% of stake
    Traded Sep 17 Filed Sep 18
    ↗
  2. Robert C Patent Director
    Sale
    $923K 10,000 shares at $92.29 12% of stake
    Traded Aug 10 Filed Aug 12
    ↗
  3. Daniel F Dougherty CFO
    Buy
    $90K 1,000 shares at $89.98 +3.1% to stake
    Traded Jul 23 Filed Jul 27
    ↗
  4. Nick Rosenberg Executive Vice President
    Planned sale
    $190K 1,897 shares at $100.41 7.9% of stake
    Traded Jun 30–Jul 1 Filed Jul 2
    ↗
  5. Nick Rosenberg Executive Vice President
    Planned sale
    $35K 353 shares at $100.02 1.4% of stake
    Traded Jun 26–29 Filed Jun 29
    ↗
  6. Robert C Patent Director
    Sale
    $964K 10,000 shares at $96.41 10% of stake
    Traded Jun 12 Filed Jun 15
    ↗
  7. Robert C Patent Director
    Sale
    $451K 5,000 shares at $90.21 4.9% of stake
    Traded Jun 4 Filed Jun 5
    ↗
  8. Harvey Gutman Director
    Sale
    $269K 3,000 shares at $89.58 14% of stake
    Traded May 29 Filed Jun 1
    ↗
  9. Daniel F Dougherty CFO
    Buy
    $80K 1,000 shares at $79.95 +3.2% to stake
    Traded Mar 10 Filed Mar 11
    ↗
  10. Robert C Patent Director
    Sale
    $1.4M 14,445 shares at $94.16
    Traded Jan 22–23 Filed Jan 26
    ↗
  11. Nick Rosenberg Executive Vice President
    Planned sale
    $113K 1,250 shares at $90.21 4.6% of stake
    Traded Jan 21 Filed Jan 22
    ↗
  12. Nick Rosenberg Executive Vice President
    Planned sale
    $50K 625 shares at $80.41 2.3% of stake
    Traded Dec 10, 2025 Filed Dec 12, 2025
    ↗
  13. Anthony J Fabiano Director
    Buy
    $9,978 147 shares at $67.87 +1.2% to stake
    Traded Oct 30, 2025 Filed Nov 3, 2025
    ↗
  14. Daniel F Dougherty CFO
    Buy
    $72K 1,000 shares at $71.66 +3.8% to stake
    Traded Oct 27, 2025 Filed Oct 28, 2025
    ↗
  15. Frederik F Erikson EVP & General Counsel
    Buy
    $1,373 20 shares at $68.65 +0.3% to stake
    Traded Oct 27, 2025 Filed Oct 28, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 25 stock grants, 11 share withholdings for taxes, 1 sale back to the company, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
8-K 2.02,7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A FORM DEF 14A Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $27.88M $23.94M $11.05M
Net income $77.27M $66.69M $71.1M
Net margin * 277.1% 278.6% 643.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $7.07B $7.3B $8.26B
Total equity $659.02M $729.83M $743.11M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $42.43M $148.46M $88.68M
Cash from investing -$775.45M -$369.61M -$762.96M
Cash from financing $745.07M $151.96M $867.6M
Net change in cash * $12.05M -$69.2M $193.32M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.